Nanotechnology offers innovative ways to enhance the efficacy and specificity of CTLs. Nanoparticles can be engineered to deliver specific antigens or immunomodulatory agents directly to CTLs, boosting their activity and persistence. For instance, nanoparticles can be designed to slowly release cytokines, thus maintaining a favorable microenvironment for CTL activation.
